Joy Wolfram

Associate Professor Joy Wolfram (The University of Queensland, School of Chemical Engineering) leads a groundbreaking extracellular vesicle research program with joint appointments at the Australian Institute for Bioengineering and Nanotechnology. Her work targets cardiovascular disease, kidney disease, and breast cancer by developing next-generation therapeutics through nanoparticle engineering and EV biology.

• Research Focus: Extracellular vesicle isolation, hybrid drug delivery systems, cancer immunoevasion mechanisms
• Collaboration: Partnerships with 160+ institutions across 45 countries
• Citations: Over 15,600 Google Scholar citations

Her scientific awards include:

• 2016 Amgen Scholars Ten to Watch
• 2019 Forbes 30 under 30 in Health Care
• 2021 Finnish Expatriate of the Year
• Top 1% researcher in Biology & Biochemistry (2023)

Recent publications highlight trends in EV-based diagnostics and glycan engineering for improved biotherapeutics. Key contributions include methods for scale manufacturing of EVs and understanding their role in cancer metastasis.

As a TEDx speaker and former National Institutes of Health education chair, she bridges science with public outreach. Her lab drives innovations in nanomedicine and clinical translation of extracellular vesicle therapeutics.